No.96/A /9/1, 42nd cross, 3rd Main, 8th BIock, Jayanagar Bengaluru

NGS stands for Next-Generation Sequencing, and in simple terms, it’s a genetic test that reads through the DNA or RNA of cancer cells looking for the specific mutations actually driving that tumour’s growth. Older testing methods could usually check one gene, maybe a handful, at a time. NGS reads hundreds, sometimes thousands, in a single run. That shift matters enormously, because cancer isn’t one disease with one cause. It’s driven by different mutations in different patients, even when the cancer type on paper looks identical.

Dr. Sandeep Nayak, who provides Best Cancer Treatment in Bangalore, explains why this test changed how treatment decisions actually get made. “Two patients can both have lung cancer, look similar on a scan, and still have completely different tumours at the molecular level. One might have an EGFR mutation, another might not have any targetable mutation at all. NGS is what tells us that difference. Without it, we’re essentially treating based on the cancer’s location rather than what’s actually driving it, which is a much blunter approach than what’s possible today.”

Curious whether NGS testing applies to your specific diagnosis?

How Does NGS Actually Work?

Bit more involved than the older single-gene tests, but the payoff’s worth it.

A tumour sample gets collected. Usually from a biopsy or whatever tissue came out during surgery. Blood-based liquid biopsy works too when getting actual tissue isn’t easy. Our blog on what is liquid biopsy in cancer diagnosis covers exactly how that blood-based option works when tissue access is difficult.

DNA or RNA gets pulled out and sequenced. The genetic material breaks down and gets read at a huge scale, all in one pass, generating a mountain of data about what’s actually going on in that tumour genetically.

Software does the sorting. Bioinformatics tools comb through that data hunting for mutations known to drive cancer, checking everything against massive databases built from years of prior findings.

Then results get matched to actual treatment. Once mutations are found, they get lined up against approved targeted therapies, immunotherapy markers, sometimes relevant trials too. That’s the part that turns raw data into something a doctor can actually act on.

Why Does NGS Matter More Than Older Testing Methods?

A few specific advantages explain why this approach has become so central to modern cancer care.

It tests many genes at once, not just one. Older methods required deciding which single gene to check, often guessing based on cancer type alone. NGS removes that guesswork by scanning broadly from the start.

It catches mutations that wouldn’t otherwise be tested for. Rare or unexpected mutations that a narrower test might never have looked for can still get identified, sometimes opening treatment options nobody anticipated. Our blog on immunotherapy vs targeted therapy covers how these NGS findings directly determine which of these two treatment paths actually applies to a given patient.

It helps identify resistance mutations over time. When a targeted therapy stops working, repeat NGS testing can reveal new mutations that have emerged, explaining the resistance and sometimes pointing toward a next-line treatment option.

It supports more personalized treatment planning overall. Rather than treating based on cancer type alone, NGS results allow treatment to be built around what’s actually driving that specific tumour’s behaviour.

Why Choose MACS Clinic for NGS Testing?

Dr. Sandeep Nayak’s team at MACS Clinic uses NGS testing as a core part of precision oncology, not an optional add-on offered only in select cases. For patients where a targeted mutation or immunotherapy marker could genuinely change the treatment approach, NGS results are reviewed alongside surgical, medical, and radiation oncology input before any plan is finalized.

For patients whose test results reveal specific actionable mutations, treatment gets built around that finding directly, whether that means targeted therapy, immunotherapy, or a relevant clinical trial. Curious whether NGS testing applies to your diagnosis? Reach the team at +91 9482202240.

FAQs

Is diagnostic staging laparoscopy the same as the actual cancer surgery?

No. It’s a separate, smaller procedure done specifically to gather information before deciding on the bigger surgery. Sometimes both happen in the same session if findings support proceeding immediately.

How long do results usually take to come back?

Somewhere between one and two weeks, roughly. Depends on the lab and how complex the panel is. Turnaround’s gotten a lot faster as the technology’s matured over the years.

Does every round of testing need a brand new biopsy?

Not always, no. Tissue from an earlier biopsy or surgery often works fine. A fresh sample or liquid biopsy tends to come into play mainly when checking for resistance later on.

Can results from this actually shift a treatment plan already in motion?

Absolutely, and that happens more than people expect. A new resistance mutation shows up, or something actionable gets caught that was missed before, and suddenly there’s an option on the table that wasn’t there at the start.

Disclaimer: This content is published for educational and informational purposes only.